Bristol Myers Squibb (BMY) closed at $59.20 in the latest trading session, marking a +2.65% move from the prior day. The stock's change was more than the S&P 500's daily gain of 2.51%. At the same ...

From a valuation standpoint, Pfizer appears attractive relative to the industry and is trading below its five-year mean.